Literature DB >> 8040902

Intact splenic function in cystic fibrosis.

N J Barrios1, M Kiernan, R Beckerman, S Davis.   

Abstract

Patients with cystic fibrosis (CF) suffer from severe chronic pulmonary infections but rarely develop bacteremia/septicemia suggestive of an intact splenic mononuclear phagocyte function. The splenic function of 25 patients diagnosed with CF, aged 2 to 37 years, was evaluated using erythrocyte pit count by direct interference contrast microscopy. Results were compared with patients with sickle cell disease and normal individuals. All CF patients displayed normal splenic function by pit count. The mean percentage of pitted erythrocytes was 0.20 +/- 0.28 (range: 0.0% to 1.0%) versus 0.19 +/- 0.33 (range: 0.0% to 1.4%) in normal eusplenic controls. There were no episodes of bacteremia or septicemia despite recurrent acute exacerbations of chronic bacterial bronchitis and the use of central lines. We conclude that splenic function in CF is unabridged and may account for the rarity of bacteremia/septicemia in patients with CF despite the high prevalence of chronic bronchial infection in this population.

Entities:  

Mesh:

Year:  1994        PMID: 8040902      PMCID: PMC2607639     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  8 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

2.  Antibody responses to influenza virus vaccine in patients with cystic fibrosis.

Authors:  B J Feery; P D Phelan; H A Gallichio; A W Hampson
Journal:  Aust Paediatr J       Date:  1979-09

3.  Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  J Pediatr       Date:  1978-08       Impact factor: 4.406

4.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report.

Authors:  J T Casper; S Koethe; G E Rodey; L G Thatcher
Journal:  Blood       Date:  1976-02       Impact factor: 22.113

6.  Hypogammaglobulinemia in patients with cystic fibrosis.

Authors:  W J Matthews; M Williams; B Oliphint; R Geha; H R Colten
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

7.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Reticuloendothelial clearance in cystic fibrosis and other inflammatory lung diseases.

Authors:  E C Mantzouranis; F S Rosen; H R Colten
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.